Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol-Nimodipine for Delayed Cerebral Ischemia in aSAH
NCT04148105Phase 4Terminated
- Sponsor
- Henry Ford Health
- Start
- Nov 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Henry Ford Health. Started Nov 2019; status: terminated.
02
Drugs
cilostazol
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04148105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148105.